Brief: Anavex Life Sciences Reports Fiscal 2023 Year End Financial Results And Provides Business Update
27/11/2023 14:42
Nov 27 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES REPORTS FISCAL 2023 YEAR END
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* ANAVEX LIFE SCIENCES CORP - CASH AND CASH EQUIVALENTS OF
$151.0
MILLION AT SEPTEMBER 30, 2023 COMPARED TO $149.2 MILLION AT
SEPTEMBER 30, 2022
* ANAVEX LIFE SCIENCES CORP - QTRLY NET LOSS PER SHARE BASIC
AND
DILUTED $0.12
Source text for Eikon: ID:nGNXC8RR0
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board